Sanofi and Regeneron Pharmaceuticals, Inc.
Dupixent MyWay Program
Information last checked July 1, 2026
Contact info
- Phone
- 1-844-387-4936
- Fax
- 1-844-387-3970
Eligibility
- Patient must be uninsured or underinsured.
- Patients with Medicare Part D should contact the program.
- Program also providers co-pay assistance.
- Income limit, single
- Not published
- Income limit, couple
- Not published
- Medical expenses can be deducted
- Not published
- Social Security number asked for
- No
- US citizenship or residency required
- Yes
Not sure where your income falls? See this year's federal poverty guidelines (opens in a new tab).
Application process
- Documents to attach
- Proof of income
- Prescriber license number
- NPI number
- Who can sign
- Physician
- Application can be faxed
- Yes
- Decision letter sent to
- Not published
Getting the medication
- Patient receives
- Varies
- Shipped to
- Patient
- Supply per shipment
- Not published
- Time to first delivery
- Not published
- Refills
- Not published
- Staying enrolled
- New application every 12 months
Medications covered
- Dupixent (dupilumab injection)